D. E. Shaw & Co., Inc. - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 74 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 2.50 and the average weighting 0.4%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,787,415
-17.4%
3,910,416
-10.1%
0.01%
-14.3%
Q2 2023$7,002,418
-42.9%
4,349,328
+2.8%
0.01%
-46.2%
Q1 2023$12,266,440
+5.9%
4,229,807
+19.8%
0.01%0.0%
Q4 2022$11,584,960
+12.7%
3,532,000
+29.9%
0.01%
+8.3%
Q3 2022$10,281,000
+97.5%
2,719,900
+307.0%
0.01%
+100.0%
Q2 2022$5,205,000
-15.5%
668,205
+0.8%
0.01%0.0%
Q1 2022$6,159,000
-57.5%
662,959
-27.9%
0.01%
-50.0%
Q4 2021$14,490,000
-2.7%
919,401
+10.5%
0.01%
-7.7%
Q3 2021$14,891,000
+17.0%
831,907
+1.6%
0.01%
+18.2%
Q2 2021$12,728,000
+29.8%
818,531
+19.8%
0.01%
+22.2%
Q1 2021$9,809,000
-18.0%
683,057
+12.0%
0.01%
-18.2%
Q4 2020$11,968,000
+188.7%
609,654
+90.6%
0.01%
+175.0%
Q3 2020$4,146,000
-4.2%
319,903
+7.7%
0.00%
-20.0%
Q2 2020$4,327,000
+155.7%
297,003
+544.8%
0.01%
+150.0%
Q2 2018$1,692,000
-8.5%
46,059
-2.9%
0.00%0.0%
Q1 2018$1,850,000
+250.4%
47,442
+374.4%
0.00%
+100.0%
Q2 2015$528,00010,0000.00%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Antipodean Advisors LLC 1,000,000$3,280,00010.95%
M28 Capital Management LP 439,300$1,440,9041.37%
Redmile Group, LLC 6,242,756$20,476,2400.84%
MAVERICK CAPITAL LTD 6,291,013$20,634,5230.49%
Baupost Group 8,123,616$26,6450.44%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 52,000$1710.25%
WASATCH ADVISORS LP 8,391,014$27,522,5250.18%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$1,722,0000.17%
STALEY CAPITAL ADVISERS INC 450,000$1,4760.09%
Virtus ETF Advisers LLC 36,100$118,4080.06%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders